Original Research
Published on 13 Mar 2025
A real-world safety surveillance study of aducanumab through the FDA adverse event reporting system
in Neuropharmacology
- 101 views
Original Research
Published on 13 Mar 2025
in Neuropharmacology
Original Research
Published on 13 Mar 2025
in Neuropharmacology
Review
Published on 13 Mar 2025
in Neuropharmacology
Original Research
Published on 12 Mar 2025
in Neuropharmacology
Original Research
Published on 12 Mar 2025
in Neuropharmacology
Original Research
Published on 11 Mar 2025
in Neuropharmacology
Original Research
Accepted on 10 Mar 2025
in Neuropharmacology
Review
Accepted on 10 Mar 2025
in Neuropharmacology
Original Research
Published on 07 Mar 2025
in Neuropharmacology
Systematic Review
Accepted on 06 Mar 2025
in Neuropharmacology
Original Research
Accepted on 06 Mar 2025
in Neuropharmacology
Systematic Review
Published on 06 Mar 2025
in Neuropharmacology
Original Research
Published on 06 Mar 2025
in Neuropharmacology
Review
Published on 06 Mar 2025
in Neuropharmacology
Original Research
Published on 06 Mar 2025
in Neuropharmacology
Review
Published on 06 Mar 2025
in Neuropharmacology